| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/IJC.31204 |
| P698 | PubMed publication ID | 29226327 |
| P50 | author | Madhur Nayan | Q58821398 |
| P2093 | author name string | David N Juurlink | |
| Peter C Austin | |||
| Antonio Finelli | |||
| Robert J Hamilton | |||
| Erin M Macdonald | |||
| Girish S Kulkarni | |||
| Canadian Drug Safety and Effectiveness Research Network (CDSERN) | |||
| P2860 | cites work | Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. | Q40162761 |
| The effect of serotonin and serotonin antagonists on bladder cancer cell proliferation | Q40318624 | ||
| Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma | Q41053553 | ||
| Palliative care and the aggressiveness of end-of-life care in patients with advanced pancreatic cancer | Q41547222 | ||
| Evidence and Clinical Relevance of Tumor Flare in Patients Who Discontinue Tyrosine Kinase Inhibitors for Treatment of Metastatic Renal Cell Carcinoma | Q41735630 | ||
| Multicenter phase II trial of combination therapy with meloxicam, a cox-2 inhibitor, and natural interferon-alpha for metastatic renal cell carcinoma | Q43291206 | ||
| Beta blockers and breast cancer mortality: a population- based study | Q44536984 | ||
| Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes | Q44611165 | ||
| NSAID use and survival after breast cancer diagnosis in post-menopausal women. | Q45143526 | ||
| Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma | Q46862623 | ||
| Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer. | Q47874565 | ||
| Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma | Q49134863 | ||
| Medication use and survival in diabetic patients with kidney cancer: A population-based cohort study. | Q51764018 | ||
| Prognostic Impact of Renin-Angiotensin System Blockade on Renal Cell Carcinoma After Surgery. | Q53612763 | ||
| NSAIDs and breast cancer recurrence in a prospective cohort study | Q28221965 | ||
| Statin use and kidney cancer survival outcomes: A systematic review and meta-analysis | Q30240035 | ||
| Using prescription claims data for drugs available over-the-counter (OTC). | Q31119847 | ||
| Competing risk regression models for epidemiologic data | Q33459711 | ||
| The genetic basis of kidney cancer: a metabolic disease | Q34087148 | ||
| The association between statin medication and progression after surgery for localized renal cell carcinoma | Q34206127 | ||
| Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials | Q34263014 | ||
| Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986-2007. | Q34324233 | ||
| Epidemiology and risk factors for kidney cancer | Q34449963 | ||
| Statin use and reduced cancer-related mortality | Q34645107 | ||
| Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma | Q34757109 | ||
| End-of-life care for lung cancer patients in the United States and Ontario. | Q35047094 | ||
| Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma | Q35214908 | ||
| Fluoxetine, an antidepressant, suppresses glioblastoma by evoking AMPAR-mediated calcium-dependent apoptosis | Q35741615 | ||
| Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma. | Q36051199 | ||
| Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada | Q36199083 | ||
| Immortal time bias in pharmaco-epidemiology | Q37023172 | ||
| Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson | Q37137953 | ||
| Association between metformin therapy and mortality after breast cancer: a population-based study | Q37193432 | ||
| International variations and trends in renal cell carcinoma incidence and mortality. | Q38275510 | ||
| Medication use and kidney cancer risk: A population-based study | Q38657343 | ||
| Beta blockers and cancer prognosis - The role of immortal time bias: A systematic review and meta-analysis | Q38834637 | ||
| Metformin Use and Kidney Cancer Outcomes in Patients With Diabetes: A Propensity Score Analysis. | Q38899340 | ||
| Statin use and kidney cancer outcomes: A propensity score analysis. | Q38900200 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney cancer | Q3242950 |
| P304 | page(s) | 1776-1785 | |
| P577 | publication date | 2018-01-03 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Medication use and kidney cancer survival: A population-based study | |
| P478 | volume | 142 |
Search more.